(Q36143058)

English

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jean Wactawski-Wende

15

object named as

Jean Wactawski-Wende

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Garnet L Anderson

object named as

Garnet L Anderson

1

0 references

4

object named as

Lewis H Kuller

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

JoAnn E. Manson

5

object named as

JoAnn E Manson

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Judith K. Ockene

12

object named as

Judith Ockene

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rowan T Chlebowski

2

object named as

Rowan T Chlebowski

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

10

object named as

Dorothy Lane

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

object named as

Margery Gass

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

F Allan Hubbell

9

object named as

F Allan Hubbell

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

13

object named as

Thomas Rohan

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Aaron K Aragaki

3

object named as

Aaron K Aragaki

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Robert Schenken

14

object named as

Robert Schenken

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Elizabeth Bluhm

7

object named as

Elizabeth Bluhm

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Stephanie Connelly

8

object named as

Stephanie Connelly

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Lisa Martin

11

0 references

publication date

7 March 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

476-486

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

New and translational perspectives of oestrogen deprivation in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Hormone therapy and fatal breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Postmenopausal estrogen and progestin effects on the serum proteome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Mammographic screening and risk factors for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Breast cancer after use of estrogen plus progestin in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Prediagnostic use of hormone therapy and mortality after breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Estrogen carcinogenesis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Endometrial cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Global trends in breast cancer incidence and mortality 1973-1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Overview of the main outcomes in breast-cancer prevention trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

The menopause: health implications and clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 October 2017

Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

2 July 2018

Exemestane for breast-cancer prevention in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Menopause-related workload in general practice 1996-2005: a retrospective study in the UK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Effects of estrogen-only treatment in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

Hormone replacement therapy regimens and breast cancer risk(1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

23 September 2018

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412626

5 December 2018

Postmenopausal Hormone Use, Screening, and Breast Cancer: Characterization and Control of a Bias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22401913

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22401913

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22401913

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unopposed estrogen therapy and the risk of invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22401913

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/22401913

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70075-X

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36143058&oldid=2063156668"